[Use of thromboelastography prior to systemic thrombolysis in patients treated with DOACs - case series]

Lóránd Hegyi1, Péter Klivényi1,2, Alex Beke1

  • 1Szegedi Tudományegyetem, Szent-Györgyi Albert Orvostudományi Kar, Szent-Györgyi Albert Klinikai Központ, Neurológiai Klinika, Szeged.

Ideggyogyaszati Szemle
|July 28, 2025
PubMed

Insights

Direct oral anticoagulants (DOACs) complicate acute ischemic stroke treatment. Viscoelastic tests like RVV and ECA rapidly assess DOAC effect, aiding thrombolysis decisions in patients with unknown anticoagulant history.

Area of Science:

  • Cardiology
  • Neurology
  • Hematology

Background:

  • Direct oral anticoagulants (DOACs) are increasingly used, posing challenges for acute ischemic stroke management.
  • Thrombolysis is contraindicated within 48 hours of DOAC intake, necessitating accurate compliance assessment.
  • Accurate patient history of DOAC use is often unavailable, complicating treatment decisions.

Observation:

  • Viscoelastic tests, specifically Russell's viper venom (RVV) and Ecarin assay (ECA), were performed using a thromboelastograph.
  • These tests were applied to 25 acute ischemic stroke patients with uncertain DOAC history.
  • The tests provided information on anticoagulant effect and patient compliance based on coagulation time.

Findings:

  • DOAC therapy ineffectiveness was observed in 11 cases, with 9 confirmed by heteroanamnesis.
  • Thrombolysis was enabled in 4 patients based on test results.
  • One hemorrhagic complication occurred, linked to undiagnosed chronic lymphocytic leukemia.

Implications:

  • DOAC-specific viscoelastic tests (RVV, ECA) offer rapid assessment of recent DOAC intake (within 48 hours).
  • These tests facilitate identification of eligible patients for thrombolysis.
  • The assays assist clinicians in determining compliance, assessing thrombolysis possibility, and expediting treatment decisions.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
37
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23